Merimepodib

Merimepodib
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T3444-1mg 1 mg -

7 - 10 business days*

39.00€
TGM-T3444-1mL 1 ml -

7 - 10 business days*

88.00€
TGM-T3444-5mg 5 mg -

7 - 10 business days*

89.00€
TGM-T3444-10mg 10 mg -

7 - 10 business days*

159.00€
TGM-T3444-25mg 25 mg -

7 - 10 business days*

290.00€
TGM-T3444-50mg 50 mg -

7 - 10 business days*

527.00€
TGM-T3444-100mg 100 mg -

7 - 10 business days*

761.00€
 
Description: Merimepodib (VX-497) is a novel, noncompetitive inhibitor of inosine monophosphate... more
Product information "Merimepodib"
Description: Merimepodib (VX-497) is a novel, noncompetitive inhibitor of inosine monophosphate dehydrogenase (IMPDH). Target: HBV, HCV Protease, Antiviral, Dehydrogenase. Smiles: COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@H]3CCOC3)c2)ccc1-c1cnco1. References: Jain J, et al. VX-497: a novel, selective IMPDH inhibitor and immunosuppressive agent. J Pharm Sci. 2001 May,90(5):625-37.
Keywords: VX-497, VI-21497
Supplier: TargetMol
Supplier-Nr: T3444

Properties

Application: Targets IMP dehydrogenase [EC:1.1.1.205] (IMPDH, guaB)
MW: 452.46 D
Formula: C23H24N4O6

Database Information

CAS : 198821-22-6| Matching products
KEGG ID : K00088 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Merimepodib"
Write a review
or to review a product.
Viewed